Literature DB >> 2052704

Focal nodular hyperplasia of the liver: assessment with contrast-enhanced TurboFLASH MR imaging.

D Mathieu1, A Rahmouni, M C Anglade, B Falise, C Beges, P Gheung, J J Mollet, N Vasile.   

Abstract

Twenty-two patients with 25 cases of focal nodular hyperplasia (FNH) proved with pathologic study were imaged with a TurboFLASH (fast low angle shot) sequence combined with bolus administration of gadolinium tetraazacyclododecanetetraacetic acid (DOTA), spin-echo (SE) T2-weighted sequences, and postcontrast T1-weighted sequences. FNH-liver signal-difference-to-noise ratios were quantified; the features of the central scar were qualitatively analyzed. On SE T2-weighted images, all FNHs were hyperintense; in two cases the central scar exhibited a high signal intensity associated with hypointense areas corresponding to fibrous tissue within the branches of the scar. Unenhanced TurboFLASH images always demonstrated the FNHs as hypointense and always depicted the central scar as a hypointense area within the lesion. After bolus injection, arterial enhancement of FNH was clearly seen, and in 10 of 25 lesions, enhancement within the scar was seen 40-80 seconds after injection. Both unenhanced and enhanced TurboFLASH sequences produced the best signal-difference-to-noise ratios in comparison with T2-weighted images.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2052704     DOI: 10.1148/radiology.180.1.2052704

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  11 in total

1.  Atypical presentation of focal nodular hyperplasia.

Authors:  Cheng-Maw Ho; Po-Huang Lee
Journal:  BMJ Case Rep       Date:  2010-01-13

Review 2.  Evaluation of nonmalignant liver masses.

Authors:  Wojciech Blonski; K Rajender Reddy
Journal:  Curr Gastroenterol Rep       Date:  2006-02

3.  Enhancement characteristics of hepatic focal nodular hyperplasia and its scar by dynamic magnetic resonance imaging.

Authors:  L Martí-Bonmatí; C Casillas; R Dosdá
Journal:  MAGMA       Date:  2000-07       Impact factor: 2.310

4.  Follow-up result afters negative findings on unenhanced hepatic MR imaging for hepatic metastasis from rectal cancer.

Authors:  Joon Seok Lim; Myeong-Jin Kim; Kang Young Lee; Nam Kyu Kim; Jin-Sub Choi; Joo Hee Kim; Young Taik Oh; Won Ho Kim; Ki Whang Kim
Journal:  Korean J Radiol       Date:  2004 Oct-Dec       Impact factor: 3.500

5.  Focal nodular hyperplasia of the liver in men: is presentation the same in men and women?

Authors:  A Luciani; H Kobeiter; P Maison; D Cherqui; E-S Zafrani; D Dhumeaux; D Mathieu
Journal:  Gut       Date:  2002-06       Impact factor: 23.059

6.  Quantitative correlation between uptake of Gd-BOPTA on hepatobiliary phase and tumor molecular features in patients with benign hepatocellular lesions.

Authors:  Edouard Reizine; Giuliana Amaddeo; Frederic Pigneur; Laurence Baranes; François Legou; Sebastien Mulé; Benhalima Zegai; Vincent Roche; Alexis Laurent; Alain Rahmouni; Julien Calderaro; Alain Luciani
Journal:  Eur Radiol       Date:  2018-05-02       Impact factor: 5.315

Review 7.  Imaging of metastases to the liver.

Authors:  A E Mahfouz; B Hamm; D Mathieu
Journal:  Eur Radiol       Date:  1996       Impact factor: 5.315

8.  Diagnosis and management of hepatic focal nodular hyperplasia.

Authors:  A Venturi; F Piscaglia; G Vidili; S Flori; R Righini; R Golfieri; L Bolondi
Journal:  J Ultrasound       Date:  2007-08-01

9.  Dynamic contrast-enhanced MR imaging of fibrolamellar hepatocellular carcinoma.

Authors:  K Corrigan; R C Semelka
Journal:  Abdom Imaging       Date:  1995 Mar-Apr

Review 10.  Distinguishing benign from malignant liver tumours.

Authors:  Jay P Heiken
Journal:  Cancer Imaging       Date:  2007-10-01       Impact factor: 3.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.